No Data
Zymeworks Drops as Wells Fargo Cuts on Valuation
At a critical moment, who is "targeting" Beigene with investigation rumors again?
It's hard to defend against sneak attacks. Recently, in an article by Investor Network, Cai Jun reported that Beigene (688235.SH, hereinafter referred to as the "company") was caught in an investigation rumor. On the afternoon of October 25, the company issued a statement on WeChat official account, stating that an employee is cooperating with the relevant investigation, and the matter has nothing to do with the company. Up to now, the company has reached a critical point of breaking even. Any slight change may affect its performance and global strategy. As a leading domestic innovative drug company, its overseas market is booming, while domestically it is catching up with the industry leaders. However, at critical moments, various underhanded tactics and actions could potentially alter the whole situation. Moreover, with the current new round of national...
beigene received 0.063 million shares of attributable issuance from restricted stock units.
Beigene (06160) announced that on October 29, 2024, 0.063 million shares were issued due to the allocation of restricted share units under the equity incentive plan (excluding company directors).
Beigene (06160.HK) obtained an issuance of 0.063 million shares due to restricted share units being granted.
On October 30, beigene (06160.HK) announced that on October 29, 2024, 0.063 million ordinary shares were issued due to the attribution of restricted share units granted under the equity incentive plan (excluding company directors).
BEIGENE: DATE OF AUDIT COMMITTEE MEETING
BeiGene Ltd. Announces New Board Composition
No Data
No Data
